Log In
BCIQ
Print this Print this
 

AmBiL

  Manage Alerts
Collapse Summary General Information
Company Taiwan Liposome Co. Ltd.
DescriptionLiposomal formulation of amphotericin B
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationFungal infection
Indication DetailsTreat systematic fungal infection
Regulatory Designation
PartnerNovartis AG;
Novartis AG;
Sam Chun Dang Pharmaceutical Co. Ltd.;
Yung Shin Pharmaceutical Industrial Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/18/2013

Undisclosed

0

Undisclosed

Get a free BioCentury trial today